Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog
about
Microbiota and chronic inflammatory arthritis: an interwoven linkBiologic efficacy optimization--a step towards personalized medicineMy treatment approach to rheumatoid arthritisThe effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responsesPredictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.Biologics registers in RA: methodological aspects, current role and future applications.The Effect of Stopping Smoking on Disease Activity in Rheumatoid Arthritis (RA). Data from BARFOT, a Multicenter Study of Early RAAlcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden: data from BARFOT, a multicenter study on early RAConsistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers.Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis - a prospective cohort study.Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significanceFeasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Three cases of previous smokers with rheumatoid arthritis who did not respond to tumor necrosis factor inhibitors were treated successfully with an anti-interleukin-6 receptor antibodySmoking and pulmonary fibrosis: novel insights.Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquineSerum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexateIdentification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response.Environmental and gene-environment interactions and risk of rheumatoid arthritis.Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatment.Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material.Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis.Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid ArthritisEffect of Exposure to Tobacco Smoke on Response to Anti-Tumor Necrosis Factor-Alpha Treatment in Patients with Rheumatoid Arthritis.Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.Cigarette smoking and musculoskeletal disorders.Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico.Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate.A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study.Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis.DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Risk estimation in rheumatoid arthritis: from bench to bedside.Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.
P2860
Q26739010-320099F7-ACC8-4582-AE54-08A2E125CE6DQ26783657-12BB8336-FEAD-4A53-A3F5-C04966642B0AQ26829955-0F4A64C9-E6E6-4B6A-9B84-6F399E690F15Q27022645-660A4BC4-45BB-41F6-A864-AD3FB280BB31Q27692641-5277DFBA-64D6-4E43-93D9-4A45C87ADE8DQ30234303-41180FDB-6B63-460C-8D96-E9658784FB44Q30575606-924AAF31-44CF-443C-A5EC-47298886FF2CQ30656861-75A35484-7B3D-4E78-B8F4-B5D39614E3F3Q30936806-4E92DC5F-A158-467C-8902-73F0CCA5E481Q31041008-F87166B6-323F-4B1A-B8EF-E16AEDF4D096Q33747444-20C1A268-2745-41AA-83AA-3CC250F10AFCQ33892353-3F5E7C92-DBA5-4EB1-A736-72185D2E043CQ33893385-1244BAC6-D4DA-4D5C-BB8F-BBA65FE05390Q34374946-18CC3329-BD39-4DA0-95E9-A4EBFEA45F3FQ34559803-AA1ED95F-6FB0-4A0B-9D97-81872DB6AB2EQ35026728-2A8FD497-AA73-4136-932E-02B32DA81BC4Q35101727-E2CE5D5C-D1BB-49D7-B5DE-2701C47F1D44Q35174817-AE2C62D2-63A2-49B4-977C-12B024904812Q35557430-4ECEDBC0-59A3-44EB-B87B-F5BCC5E315C9Q35792901-F59BCD34-75D5-43D2-B7E1-41979D67EB4EQ35891851-D93C5758-04F9-4FB5-ADCD-0BCF5CD710FEQ36027446-2E04C2FB-4E22-4C30-8DD6-8CCCC3D4DAE8Q36056195-25505659-6C87-4388-8FAC-ADD9258283B4Q36110733-7BCFB0AD-5C17-4D50-9B08-42AAD2B11E4DQ36183760-C9ABB6C5-4FF1-4B9F-BFA6-34B8C9513E2BQ36306270-76765DBD-B769-4228-B459-3DBD4FA99408Q36439968-BB3DD0D5-A5B5-4000-AB58-078D70B96639Q36633164-C3E00C42-736E-4B14-9E97-0CBBFDBEDFF0Q36693727-BA872878-065F-4F42-AA02-DC9D6D68EA9AQ36853631-0B060B87-CDDE-4149-933F-A8CA1C0B0BA1Q36907694-D77E409A-20BA-41DC-BE2A-EC585E55A8D3Q37013908-0CB5C7D6-D83C-4695-B8EE-E900008F410AQ37191106-7218FB42-8C08-4892-B823-135195837F20Q37456609-02EFE3ED-CA52-4917-AFB4-D9754CF5EC70Q37470261-918A29E8-ED31-43FB-A091-A3C5A74F2221Q37587409-5119D9A4-0078-4F7C-96A8-6A8D2E251A2DQ37728616-9A1414F5-0805-46A2-9974-F8D57347A0DDQ37883018-4FCF81FC-48E0-49B1-A433-C8F6249F6A97Q38182346-3238E8EA-0CFA-4CCC-8EE9-6E3F21E0377DQ38286234-EB021923-5BFC-4272-8053-83F82C46BEB6
P2860
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2010
@uk
name
Patients with early rheumatoid ...... is and the Swedish Rheumatolog
@en
Patients with early rheumatoid ...... is and the Swedish Rheumatolog
@nl
type
label
Patients with early rheumatoid ...... is and the Swedish Rheumatolog
@en
Patients with early rheumatoid ...... is and the Swedish Rheumatolog
@nl
prefLabel
Patients with early rheumatoid ...... is and the Swedish Rheumatolog
@en
Patients with early rheumatoid ...... is and the Swedish Rheumatolog
@nl
P2093
P2860
P921
P356
P1476
Patients with early rheumatoid ...... is and the Swedish Rheumatolog
@en
P2093
Annmarie Wesley
Camilla Bengtsson
Johan Askling
Maria Seddighzadeh
Saedis Saevarsdottir
Sara Wedrén
Staffan Lindblad
P2860
P356
10.1002/ART.27758
P577
2010-12-28T00:00:00Z